Palbociclib has a unique mechanism of action which helps in delaying disease progression when co-administered with hormonal therapies
APAC region contributed around 50% of the in-vitro diagnostics market in 2022
OriCiro's synthetic biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
The new project further expands the partner's long-term collaboration on new technologies for R&D
A study by Agharkar Research Institute (ARI), Pune, has discovered that a protein secreted from intervertebral disc cells induces disc regeneration in aged degenerated discs
Partnership to leverage the Helix Laboratory Platform and QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise
Seeks partnership between government and private medical colleges for providing superior medical education
Biocytogen will provide a license to Hansoh Pharma for their selected fully human antibody molecules
BDRs journey for the treatment of Prostate Cancer started with Abiratarone Acetate, then Leuprolide Acetate followed by Enzalutamide and, then Degarelix and Triptorelin.
Subscribe To Our Newsletter & Stay Updated
